No results displayed.
Inside "Interviews with Patients and Researchers":
@CancerQuest on Twitter:
Related to this page:
Was this page helpful?
|
Page 12 of 45 | <Previous : Next> Jump to Page:

Interview with Dr. Michael Comb

Dr. Michael Comb
President & CEO, Cell Signaling Technology, Inc

Dr. Comb is interested in the communication that occurs within and between cells.  In cancer, this communication is defective.  By understanding the nature of the communication and the ways that it is changed in cancer, he hopes to help develop better treatments and diagnostic tools.  In this interview he discusses his work on cell signaling and the development of new model systems to study cancer.  He also talks about the need for young people to get involved in biomedical research.

Image of Dr. Michael Comb

Questions and Answers

About Michael Comb(Time: 15 sec)
How Comb Became Involved in Cancer Research And Signaling Pathways(Time: 1 min 03 sec)
Signaling Pathways and Cancer(Time: 2 min 29 sec)
Making Cell Signaling Technology More Accesible(Time:  1 min 03 sec)
Identifying the Problem With Cells at a Molecular Level(Time: 1 min 35 sec)
Unigraphs and the Need For Better Model Systems(Time: 1 min 23 sec)
Developing Better Tools to Identify More Signaling Pathways(Time: 1 min 6 sec)
Current Limitations Associated with Cell Signaling Pathway Research(Time:  2 min 53 sec)
The Use of Antibodies to Discover Cell Damage(Time: 1 min 21 sec)
Students Working at Cell Signaling Technology(Time: 52 sec)
Encouraging the Youth to Engage in Science(Time: 1 min 02 sec)
Page 12 of 45 | <Previous : Next>
Last Modified: 10/08/2010 Print Email Page Share
Copyright ©2012 Emory University. All rights reserved.
Direct questions and comments to cancerquest@emory.edu.
Disclaimer | Legal Policies | Contact
Follow @CancerQuest on Twitter
CancerQuest Dictionary
Follow us on: